News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Aligos Therapeutics signs exclusive licensing deal with Amoytop for HBV treatment in Greater China
Friday, April 17, 2026Aligos Therapeutics has entered into an exclusive licensing agreement with Xiamen Amoytop Biotech Co Ltd to develop and commercialise pevifoscorvir sodium for chronic hepatitis B virus HBV infection in Greater China including Mainland China Taiwan Ho...
Jeito Capital Closes Record $1.2 Billion Jeito II Fund for European Biopharma Investments
Friday, April 17, 2026Parisbased Jeito Capital has closed billion for its second fund marking the largest raise by an independent European biopharmafocused venture capital fund
Boehringer Ingelheim and Zai Lab Partner on DLL3-Targeting Combination Study in Lung and Neuroendocrine Cancers
Thursday, April 16, 2026Boehringer Ingelheim and Zai Lab have announced a clinical collaboration to evaluate a dual DLLtargeting treatment approach The partnership will focus on a Phase IbII study assessing the safety tolerability
Clinilabs Completes Routine FDA Inspection with No Observations
Wednesday, April 15, 2026Clinilabs LLC a global fullservice contract research organisation CRO focused on the development of medicines and medical devices for the central nervous system has successfully completed a routine inspection by the US Food and Drug Administration FD...
Dyve Biosciences and Moffitt Cancer Center Report Promising Results for Novel Topical Therapy Targeting Tumour Acidity
Wednesday, April 15, 2026Dyve Biosciences in collaboration with Moffitt Cancer Center has reported encouraging results for an investigational topical therapy designed to target tumour acidity across the body
U.S. FDA Grants RMAT Designation to GS-100 for NGLY1 Deficiency
Wednesday, April 15, 2026Grace Science LLC has received Regenerative Medicine Advanced Therapy RMAT designation from the US Food and Drug Administration FDA for GS an investigational gene therapy for the treatment of NGLY deficiency
EU Records Significant Pharma Export Uptick in 2025 Amid Competitiveness Concerns
Wednesday, April 15, 2026The European Union achieved a record trade surplus of bn in pharmaceuticals for driven by a yearonyear increase in export value though analysts warn of potential frontloading ahead of challenges
Septerna Begins Phase 1 Trial of Oral SEP-479 for Hypoparathyroidism
Tuesday, April 14, 2026Septerna Inc has started a Phase clinical trial of SEP an oral small molecule designed to treat hypoparathyroidism The company has dosed the first participants in the study
OXB Introduces Fast-Track Offering to Speed Up Viral Vector Development and Manufacture
Tuesday, April 14, 2026OXB has launched a new fasttrack development and manufacturing service to support programmes using adenoassociated viral AAV and lentiviral LV vectors The offering is designed to provide a quicker route to GMP manufacturing for eligible biotech clien...
Kymera Therapeutics Receives FDA Fast Track Status for KT-621 in Asthma Treatment
Tuesday, April 14, 2026Kymera Therapeutics Inc has received Fast Track designation from the US Food and Drug Administration for KT an oral STAT degrader developed to treat moderate to severe eosinophilic asthma
